Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ)

17.96 -0.17 (-0.94%) At close: 03:04PM CST

Guangdong Hybribio Biotech Co.,Ltd.

50 Bonham Strand
27th Floor, Strand 50
Sheung Wan
Hong Kong
852 2851 8029
https://www.hybribio.cn

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 2,356

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Qiaozhong Guan	GM & Director	N/A	N/A	1949
Mr. Qinghui Li	Fin. Director	N/A	N/A	1965
Mr. Longxu Xie	Deputy GM & Director	N/A	N/A	1970
Mr. Zhisheng Guan	Deputy GM & Non Independent Director	N/A	N/A	1984
Ms. Jianyu Wang	Exec. Deputy GM & Director	N/A	N/A	1961
Mr. Yi Chen	Deputy GM & Board Sec.	N/A	N/A	1979
Xian Yuan	Securities Representative	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.

Corporate Governance

Guangdong Hybribio Biotech Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.